billHR4206Event Thursday, June 26, 2025Analyzed

CONNECT for Health Act of 2025

Bullish
Impact5/10

Summary

HR4206, the CONNECT for Health Act of 2025, is an early-stage bill in the House that aims to significantly expand Medicare coverage for telehealth services. If enacted, it would structurally benefit companies providing telehealth platforms and related medical devices by increasing the addressable market and reimbursement for virtual care.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR4206 aims to expand Medicare coverage for telehealth services by removing key restrictions.
  • 2.The bill is in the early committee stage in the House, with a companion bill in the Senate, indicating legislative momentum.
  • 3.No direct funding is authorized; the bill expands the scope of services eligible for Medicare reimbursement.
  • 4.Pure-play telehealth providers and integrated healthcare companies with virtual care offerings are structural beneficiaries.

Market Implications

The CONNECT for Health Act of 2025, if enacted, would create a significant tailwind for the telehealth sector by expanding Medicare reimbursement and reducing barriers to adoption. This legislative push would structurally benefit companies like Teladoc Health ($TDOC), Amwell ($AMWL), and One Medical by increasing their addressable market and driving higher utilization of their platforms and services. Larger integrated healthcare players such as UnitedHealth Group ($UNH) and CVS Health ($CVS), which have invested in virtual care capabilities, would also see increased opportunities to deliver care more efficiently and broadly. While the bill is in its early stages, its progression through Congress, especially with a companion Senate bill, suggests a long-term bullish outlook for companies positioned in the telehealth ecosystem.

Full Analysis

HR4206, the CONNECT for Health Act of 2025, was introduced in the House on June 26, 2025, and subsequently referred to the House Committees on Energy and Commerce and Ways and Means. This bill seeks to amend Title XVIII of the Social Security Act to expand access to telehealth services. Key provisions include removing geographic requirements for telehealth, expanding eligible originating sites and practitioners, and repealing the six-month in-person visit requirement for telemental health services. As an early-stage bill, its immediate market impact is limited, but it signals a legislative intent to broaden telehealth adoption. The bill does not explicitly authorize a specific funding amount. Instead, it modifies the conditions under which Medicare reimburses for telehealth services, effectively expanding the scope of services eligible for payment. The 'money trail' would involve increased Medicare outlays for telehealth services as utilization rises due to the removal of current restrictions. This means that while no new direct appropriation is specified, the bill would lead to a re-allocation of existing healthcare spending towards virtual care, benefiting providers and platforms that facilitate these services. Structural winners include pure-play telehealth platform providers like Teladoc Health ($TDOC) and Amwell ($AMWL), whose core business models are directly aligned with expanded telehealth access and reimbursement. Companies offering virtual care services, such as One Medical, and integrated healthcare providers with significant virtual care offerings, like UnitedHealth Group ($UNH) and CVS Health ($CVS), also stand to benefit. The bill's focus on removing barriers to access and expanding eligible services directly increases the market opportunity for these companies. There are no clear losers identified in the bill text, as it primarily expands access rather than restricting existing services. Given its early stage, the bill's legislative path involves committee review in both the House Energy and Commerce and Ways and Means committees. The presence of a companion bill, S1261, in the Senate, also titled the CONNECT for Health Act of 2025, indicates bipartisan and bicameral support for expanding telehealth. This increases the probability of eventual passage, though the timeline remains uncertain. No presidential actions directly amplify or conflict with this specific healthcare legislation, as the recent executive orders focus on energy and infrastructure under the Defense Production Act.

Market Impact Score

5/10
Minimal ImpactModerateMajor Market Event

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.